Genelux director granted RSUs and stock options

GENELUX Corp director Thomas John reported new equity awards rather than open-market trades.

Rhea-AI Filing Summary

GENELUX Corp director Thomas John reported new equity awards rather than open-market trades. He received 28,409 shares of common stock in the form of restricted stock units, each representing one share upon vesting. He was also granted stock options for 31,566 shares at an exercise price of $3.03 per share, expiring on June 15, 2036. Both the RSUs and the options will vest on the earlier of one year from the June 16, 2026 grant date or the company’s next annual stockholder meeting. Following these awards, John directly holds 501,193 shares of GENELUX common stock.

Insider Trade Summary

Grant/Award: 59,975 shares

Grant/Award 2 txns

Insider Thomas John

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	31,566	$0.00	$0.00
Grant/Award	Common Stock	28,409	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 31,566 contracts (Direct); Common Stock — 501,193 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.
2. F2. The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Key Figures

RSUs granted: 28,409 shares Stock options granted: 31,566 options Option exercise price: $3.03 per share +3 more

6 metrics

RSUs granted 28,409 shares Restricted stock units granted on June 16, 2026

Stock options granted 31,566 options Stock Option (Right to Buy) granted on June 16, 2026

Option exercise price $3.03 per share Conversion/exercise price for 31,566 options

Option expiration June 15, 2036 Expiration date of stock option grant

Shares held after transaction 501,193 shares Total GENELUX common shares directly owned after awards

Underlying option shares 31,566 shares Common stock underlying the stock option grant

Key Terms

restricted stock units ("RSUs"), 2022 Equity Incentive Plan, Stock Option (Right to Buy), vest upon the earlier of, +1 more

5 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2022 Equity Incentive Plan financial

"RSUs granted pursuant to the Issuer's 2022 Equity Incentive Plan."

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy) listed as a derivative security."

vest upon the earlier of financial

"The RSUs will vest upon the earlier of the one-year anniversary or the next annual meeting of stockholders."

annual meeting of stockholders financial

"Vesting occurs upon the earlier of one-year anniversary of grant or the Issuer's next annual meeting of stockholders."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GENELUX (GNLX) director Thomas John report?

Thomas John reported equity awards, not open-market trades. He received 28,409 restricted stock units and stock options for 31,566 shares, all granted on June 16, 2026 as part of his director compensation.

How many GENELUX (GNLX) RSUs did Thomas John receive and how do they work?

Thomas John received 28,409 restricted stock units. Each RSU represents a contingent right to receive one share of GENELUX common stock when it vests, effectively granting shares over time instead of an immediate cash or stock payment.

What are the terms of Thomas John’s GENELUX (GNLX) stock option grant?

He was granted stock options covering 31,566 shares of GENELUX common stock at a $3.03 exercise price. These options expire on June 15, 2036 and become exercisable only after they vest according to the specified vesting schedule.

When do Thomas John’s GENELUX (GNLX) RSUs and options vest?

Both the RSUs and the stock options vest on the earlier of two dates: the one-year anniversary of the June 16, 2026 grant date, or the date of GENELUX’s next annual meeting of stockholders, aligning vesting with his board service period.

How many GENELUX (GNLX) shares does Thomas John hold after these awards?

After the June 16, 2026 transactions, Thomas John directly holds 501,193 shares of GENELUX common stock. This figure reflects his position following the grant of 28,409 RSUs, which will convert into shares only as they vest over time.

Were Thomas John’s GENELUX (GNLX) transactions open-market buys or compensation grants?

The transactions were compensation-related grants, not market purchases. Both the 28,409 restricted stock units and 31,566 stock options were awarded under GENELUX’s 2022 Equity Incentive Plan as director compensation and will vest over a defined service period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 07:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thomas John

(Last) (First) (Middle)

C/O GENELUX CORPORATION

2625 TOWNSGATE ROAD, SUITE 230

(Street)

WESTLAKE VILLAGE CALIFORNIA 91361

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENELUX Corp [ GNLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A(1)		28,409	A	$0	501,193	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$3.03	06/16/2026		A		31,566		(2)	06/15/2036	Common stock	31,566	$0	31,566	D

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

2. The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

	/s/ Thomas Zindrick, Attorney-in-Fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)